Vault-13

Dauntless Investment Group, LLC

Milford, MI · CIK 2044285 · 13F filing filed 2026-08-13

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$57.7m reported value +96.6% vs Q1 2026
64positions
63.6%in top 10
0 new 16 added 18 reduced 0 sold out vs Q1 2026

This manager withheld holdings under SEC confidential treatment in both Q2 2026 and Q1 2026, so new and sold-out positions can't be determined.

Options: 4 call positions ($4.3m notional), 5 put positions ($65.3m notional) – listed below, not included above.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 AEON BIOPHARMA INC CL A NEW AEON AEON 12,490,154 $9.0m15.58% 15.58% AddedShares held: Q3 2025 1.1m, Q4 2025 2.1m, Q1 2026 2.5m, Q2 2026 12.5m +10.0m +9,962,379 394.1%
2 FEMASYS INC COM NEW FEMY FEMY 1,867,987 $7.8m13.54% 13.54% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.9m
3 KAZIA THERAPEUTICS LTD SPONSORED ADS KZIA KZIA 354,208 $5.0m8.65% 8.65% AddedShares held: Q3 2025 118.1k, Q4 2025 1, Q1 2026 79.8k, Q2 2026 354.2k +274.4k +274,376 343.7%
4 VALERO ENERGY CORP COM VLO VLO 10,620 $2.8m4.80% 4.80% Not comparableShares held: Q3 2025 5.4k, Q4 2025 4.2k, Q1 2026 0, Q2 2026 10.6k
5 ST JOE CO COM JOE JOE 36,167 $2.3m3.93% 3.93% AddedShares held: Q3 2025 29.2k, Q4 2025 42.7k, Q1 2026 32.3k, Q2 2026 36.2k +3.9k +3,914 12.1%
6 ADAGENE INC ADS ADAG ADAG 537,230 $2.3m3.91% 3.91% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 34.8k, Q2 2026 537.2k +502.5k +502,455 1444.9%
7 ESTABLISHMENT LABS HLDGS INC COM ESTA ESTA 25,728 $2.2m3.83% 3.83% AddedShares held: Q3 2025 0, Q4 2025 12.5k, Q1 2026 9.4k, Q2 2026 25.7k +16.3k +16,300 172.9%
8 IRSA INVERSIONES Y REP S A SPON GDS ECH 10 IRS IRS 126,542 $2.0m3.39% 3.39% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 126.5k
9 AZITRA INC COM NEW AZTR AZTR 11,292,186 $1.9m3.28% 3.28% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.0k, Q2 2026 11.3m +11.3m +11,291,186 1129118.6%
10 LINCOLN EDL SVCS CORP COM LINC LINC 31,046 $1.5m2.69% 2.69% ReducedShares held: Q3 2025 56.0k, Q4 2025 56.0k, Q1 2026 59.4k, Q2 2026 31.0k -28.4k -28,393 -47.8%
11 TIZIANA LIFE SCIENCES LTD COMMON SHARES TLSA TLSA 1,162,000 $1.5m2.58% 2.58% ReducedShares held: Q3 2025 2.7m, Q4 2025 1.8m, Q1 2026 2.2m, Q2 2026 1.2m -1.0m -1,003,231 -46.3%
12 PROFOUND MED CORP COM NEW PROF PROF 208,369 $1.4m2.40% 2.40% ReducedShares held: Q3 2025 0, Q4 2025 75.6k, Q1 2026 240.7k, Q2 2026 208.4k -32.4k -32,370 -13.4%
13 ARMATA PHARMACEUTICALS INC COM ARMP ARMP 203,891 $1.3m2.29% 2.29% AddedShares held: Q3 2025 0, Q4 2025 6.1k, Q1 2026 90.6k, Q2 2026 203.9k +113.3k +113,311 125.1%
14 LOMA NEGRA C I A S A MTN 14 SPONSORED ADS LOMA LOMA 115,186 $1.3m2.29% 2.29% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 115.2k
15 COURSERA INC COM COUR COUR 224,171 $1.3m2.19% 2.19% AddedShares held: Q3 2025 69.6k, Q4 2025 12.6k, Q1 2026 88.2k, Q2 2026 224.2k +136.0k +135,999 154.2%
16 UNIVERSAL TECHNICAL INST INC COM UTI UTI 27,990 $1.2m2.08% 2.08% AddedShares held: Q3 2025 0, Q4 2025 17.9k, Q1 2026 14.6k, Q2 2026 28.0k +13.4k +13,409 92.0%
17 QUOIN PHARMACEUTICALS LTD SPONSORED ADS QNRX QNRX 214,987 $1.0m1.80% 1.80% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 196.6k, Q2 2026 215.0k +18.4k +18,395 9.4%
18 SERVICENOW INC COM NOW NOW 10,200 $1.0m1.76% 1.76% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 10.2k
19 UNICYCIVE THERAPEUTICS INC COM NEW UNCY UNCY 214,000 $1.0m1.74% 1.74% AddedShares held: Q3 2025 0, Q4 2025 89.4k, Q1 2026 147.1k, Q2 2026 214.0k +66.9k +66,913 45.5%
20 CRESUD S A C I F Y A SPONSORED ADR CRESY CRESY 80,186 $898.9k1.56% 1.56% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 80.2k
21 THE ONCOLOGY INSTITUTE INC COM STLN STLN 163,570 $888.2k1.54% 1.54% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 462.1k, Q2 2026 163.6k -298.5k -298,487 -64.6%
22 PTC THERAPEUTICS INC COM PTCT PTCT 10,193 $831.4k1.44% 1.44% AddedShares held: Q3 2025 0, Q4 2025 4.8k, Q1 2026 8.4k, Q2 2026 10.2k +1.8k +1,831 21.9%
23 ALPHA TAU MEDICAL LTD ORDINARY SHARES DRTS DRTS 61,200 $769.9k1.33% 1.33% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 61.2k
24 TALPHERA INC COM NEW TLPH TLPH 746,051 $768.4k1.33% 1.33% AddedShares held: Q3 2025 100.0k, Q4 2025 579.3k, Q1 2026 435.2k, Q2 2026 746.1k +310.8k +310,817 71.4%
25 CHURCHILL CAP CORP XI CL A ORD SHS CCXI CCXI 38,587 $673.3k1.17% 1.17% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 38.6k
26 MAREX GROUP PLC ORD 96665EUR 96665EUR 10,324 $629.2k1.09% 1.09% ReducedShares held: Q3 2025 0, Q4 2025 22.0k, Q1 2026 20.3k, Q2 2026 10.3k -10.0k -9,998 -49.2%
27 MARATHON PETE CORP COM MPC MPC 2,264 $578.8k1.00% 1.00% ReducedShares held: Q3 2025 0, Q4 2025 5.9k, Q1 2026 4.2k, Q2 2026 2.3k -1.9k -1,892 -45.5%
28 UPWORK INC COM UPWK UPWK 67,680 $565.8k0.98% 0.98% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 67.7k
29 NEURONETICS INC COM STIM STIM 369,187 $479.9k0.83% 0.83% AddedShares held: Q3 2025 0, Q4 2025 160.9k, Q1 2026 269.2k, Q2 2026 369.2k +100.0k +99,979 37.1%
30 COGNITION THERAPEUTICS INC COM CGTX CGTX 371,701 $427.5k0.74% 0.74% ReducedShares held: Q3 2025 0, Q4 2025 466.0k, Q1 2026 431.0k, Q2 2026 371.7k -59.3k -59,299 -13.8%
31 PILGRIMS PRIDE CORP COM PPC PPC 13,721 $385.7k0.67% 0.67% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 31.4k, Q2 2026 13.7k -17.7k -17,663 -56.3%
32 MAUI LD & PINEAPPLE INC COM MLP MLP 19,362 $344.3k0.60% 0.60% AddedShares held: Q3 2025 7.3k, Q4 2025 8.0k, Q1 2026 5.4k, Q2 2026 19.4k +14.0k +13,965 258.8%
33 AIRSCULPT TECHNOLOGIES INC COM AIRS AIRS 67,360 $303.1k0.53% 0.53% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1, Q2 2026 67.4k +67.4k +67,359 6735900.0%
34 GRUPO FINANCIERO GALICIA S.A SPONSORED ADR GGAL GGAL 4,220 $211.1k0.37% 0.37% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 4.2k
35 CAL MAINE FOODS INC COM NEW CALM CALM 2,581 $207.9k0.36% 0.36% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 14.2k, Q2 2026 2.6k -11.6k -11,646 -81.9%
36 MOBILICOM LTD ORD SHS NEW MOB MOB 28,245 $144.9k0.25% 0.25% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 28.2k
37 SONIDA SENIOR LIVING INC COM SNDA SNDA 3,521 $143.7k0.25% 0.25% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.5k
38 WELLTOWER INC COM WELL WELL 619 $140.5k0.24% 0.24% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 619
39 APYX MEDICAL CORPORATION COM APYX APYX 30,249 $135.8k0.24% 0.24% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 30.2k
40 BROOKDALE SR LIVING INC COM BKD BKD 4,571 $73.5k0.13% 0.13% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 4.6k
41 JANUS LIVING INC CL A-1 JAN JAN 2,398 $68.9k0.12% 0.12% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.4k
42 TRAWS PHARMA INC COM NEW TRAW TRAW 80,574 $67.9k0.12% 0.12% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 417.0k, Q2 2026 80.6k -336.4k -336,424 -80.7%
43 ERNEXA THERAPEUTICS INC COM ERNA ERNA 6,000 $39.9k0.07% 0.07% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 6.0k
44 INNOVIVA INC COM INVA INVA 1,620 $36.8k0.06% 0.06% ReducedShares held: Q3 2025 0, Q4 2025 5.5k, Q1 2026 122.4k, Q2 2026 1.6k -120.8k -120,782 -98.7%
45 GRUPO CIBEST SA SPON ADS CIB CIB 443 $35.2k0.06% 0.06% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 443
46 AGNICO EAGLE MINES LTD COM AEM AEM 165 $25.6k0.04% 0.04% ReducedShares held: Q3 2025 26.1k, Q4 2025 320, Q1 2026 272, Q2 2026 165 -107 -107 -39.3%
47 GLOBAL X FDS GLBX MSCI COLUM COLO COLO 507 $21.1k0.04% 0.04% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 507
48 HESAI GROUP SPONSORED ADS HSAI HSAI 1,100 $20.0k0.03% 0.03% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.1k
49 RENATUS TACTICAL ACQUIS SHS CL A RTAC RTAC 1,813 $19.0k0.03% 0.03% UnchangedShares held: Q3 2025 72.4k, Q4 2025 90.5k, Q1 2026 1.8k, Q2 2026 1.8k
50 TEXAS VENTURES ACQUISITION I USD CL A ORD SHS TVA TVA 805 $8.5k0.01% 0.01% ReducedShares held: Q3 2025 17.8k, Q4 2025 39.4k, Q1 2026 4.0k, Q2 2026 805 -3.2k -3,213 -80.0%
51 JBS N.V. CL A SHS JBS JBS 674 $8.0k0.01% 0.01% ReducedShares held: Q3 2025 140.6k, Q4 2025 81.3k, Q1 2026 21.3k, Q2 2026 674 -20.6k -20,634 -96.8%
52 AMERICAN EXCEPTIONALISM ACQU ORD CL A AEXA AEXA 670 $7.9k0.01% 0.01% UnchangedShares held: Q3 2025 0, Q4 2025 19.7k, Q1 2026 670, Q2 2026 670
53 CURIS INC COM COM 10,001 $5.2k0.01% 0.01% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 658.7k, Q2 2026 10.0k -648.7k -648,724 -98.5%
54 DOUBLELINE INCOME SOLUTIONS COM DSL DSL 326 $3.6k0.01% 0.01% UnchangedShares held: Q3 2025 326, Q4 2025 326, Q1 2026 326, Q2 2026 326
55 ABRDN PLATINUM ETF TRUST PHYSCL PLATM SHS PPLT PPLT 240 $3.4k0.01% 0.01% UnchangedShares held: Q3 2025 34.5k, Q4 2025 6.9k, Q1 2026 240, Q2 2026 240
56 DAKOTA GOLD CORP COM DC DC 581 $2.5k0.00% 0.00% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 69.0k, Q2 2026 581 -68.5k -68,460 -99.2%
57 NEW AMER ACQUISITION I CORP UNIT 99/99/9999 NWAX.U NWAX.U 172 $1.8k0.00% 0.00% UnchangedShares held: Q3 2025 0, Q4 2025 42.1k, Q1 2026 172, Q2 2026 172
58 POWELL INDS INC COM POWL POWL 1 $2860.00% 0.00% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1
59 INMUNE BIO INC COM INMB INMB 100 $1630.00% 0.00% ReducedShares held: Q3 2025 0, Q4 2025 304.9k, Q1 2026 183.5k, Q2 2026 100 -183.4k -183,376 -100.0%
60 LINEAGE CELL THERAPEUTICS IN COM LCTX LCTX 100 $1310.00% 0.00% Not comparableShares held: Q3 2025 1.6m, Q4 2025 0, Q1 2026 0, Q2 2026 100
61 CAPRICOR THERAPEUTICS INC COM NEW CAPR CAPR 1 $240.00% 0.00% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 14.1k, Q2 2026 1 -14.1k -14,069 -100.0%
62 TREVI THERAPEUTICS INC COM TRVI TRVI 1 $190.00% 0.00% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1
63 HALL CHADWICK ACQUISITION CO ORD SHS CL A HCAC HCAC 1 $100.00% 0.00% Not comparableShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1
64 NORTHERN DYNASTY MINERALS LT COM NEW NAK NAK 1 $20.00% 0.00% UnchangedShares held: Q3 2025 8.7k, Q4 2025 880, Q1 2026 1, Q2 2026 1

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
ISHARES TR IWM · Put IWMPut 120,000 $36.1m120.0k shares Added
INVESCO QQQ TR QQQ · Put QQQPut 16,300 $12.0m16.3k shares Not comparable
ELECTRONIC ARTS INC EA · Put EAPut 46,000 $9.4m46.0k shares Not comparable
VANECK ETF TRUST SMH · Put SMHPut 7,100 $4.7m7.1k shares Not comparable
SPDR SER TR XBI · Put XBIPut 20,000 $3.2m20.0k shares Not comparable
ALPHABET INC GOOG · Call GOOGCall 3,500 $1.2m3.5k shares Not comparable
AMAZON COM INC AMZN · Call AMZNCall 4,400 $1.0m4.4k shares Not comparable
MICROSOFT CORP MSFT · Call MSFTCall 2,800 $1.0m2.8k shares Not comparable
META PLATFORMS INC META · Call METACall 1,700 $957.6k1.7k shares Not comparable

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
FEMASYS INC 13G · filed 2025-11-14 9.9% +4.5 pts 13G 2025-11-14
AEON BIOPHARMA INC AEON · 13G · filed 2025-03-03 AEON 9.7%≈ $77.8k new 13G 2025-03-03
AZITRA INC 13G · filed 2026-06-25 9.6% new 13G 2026-06-25
KAZIA THERAPEUTICS LTD KZIA · 13G · filed 2026-10-02 KZIA 5.4% +5.4 pts 13G 2026-10-02